Master Limited Partnerships (MLPs) combine the tax benefits of a partnership with the liquidity of publicly traded securities. They’re one of the most underrated investment classes today and should be considered by anyone looking...
Latest articles
Bitcoin Nears Breakout as Altcoins Rally Amid Turmoil
Market Pulse: Crypto mood ticked higher after 20 Bitcoin indicators flipped bullish almost in unison, signaling a potential breakout for Bitcoin and boosting altcoins off recent lows. The broader market held steady despite...
ODD Shares Plunge 49%—Class Action Could Signal More Trouble
Introduction ODDITY Tech Ltd. (NASDAQ: ODD) – a recently public, AI-driven beauty and wellness platform – saw its shares crash nearly 50% in one day after an alarming guidance cut, erasing over two-thirds of its market value...
Oil Surges Past $108 While Bitcoin Defends $67K
Opening Recap Market Pulse: Nifty drifts lower into the FY26 finish line as West Asia war fears push crude above $108 and foreign inflows evaporate. U.S. indexes chop around their 200-day moving average, with swing traders eyeing...
OGI’s Big Move: Shareholder Approval for Sanity Group!
Overview – A Transformative Cross-Border Acquisition Organigram Global Inc. (NASDAQ/TSX: OGI), a Canadian licensed cannabis producer, has won shareholder approval to acquire Germany’s Sanity Group GmbH in a major cross-border...
Bearish Markets and Bullish Swing Trade Picks
Market Pulse: Global energy jitters and currency slides stamped a bearish mood as benchmarks skidded through a fifth straight weekly drop after Friday’s sell-off. Key Movers: Crude ripped past $108 on Iran tensions, the rupee...
CORT ALERT: Class Action Looms After FDA Rejection!
Company Overview Corcept Therapeutics Incorporated (NASDAQ: CORT) is a commercial-stage biopharmaceutical company focused on developing drugs that modulate the effects of cortisol, a stress hormone (intellectia.ai). Its flagship...
Markets Slide on Geopolitics: ACME Solar, XRP Trade Alerts
Opening Recap Market Pulse Equities across India drifted lower for a fifth straight week as Middle East tensions sent traders into selling mode, with benchmark indices not offering any respite. Key Movers Technical setups in ACME...
CORT ALERT: Class Action Looms After FDA Rejection!
Corcept Therapeutics (NASDAQ: CORT) faces intense scrutiny after the FDA’s surprise rejection of its lead drug candidate, relacorilant, sent the stock crashing and prompted a securities class action. On December 31, 2025, Corcept...
IDE: FDA Filing for Glucotrack Could Drive 2025 Gains!
Company Overview & FDA IDE Catalyst GlucoTrack, Inc. (NASDAQ: GCTK) is a micro-cap medical technology company developing a fully implantable continuous blood glucose monitor (CBGM) for people with diabetes (www...
EDSA: Edesa Biotech’s Vitiligo Program Enrollment in 2026!
Edesa Biotech, Inc. (NASDAQ: EDSA) is a clinical-stage biopharmaceutical company focused on developing novel, host-directed therapies for immune-mediated and inflammatory diseases (www.edesabiotech.com) (www.biospace.com). The...
